Q2 2025 Holdings
Filed 2025-08-14 | 37 holdings | $415.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $87.4M | 924,204 | 21.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $75.8M | 752,712 | 18.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $43.2M | 78,311 | 10.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $41.4M | 494,424 | 10.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $23.9M | 30,700 | 5.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $16.7M | 155,200 | 4.0% |
| Merus N V | COM | N5749R100 | $15.6M | 296,750 | 3.8% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $14.7M | 81,717 | 3.5% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $13.3M | 190,752 | 3.2% |
| Verona Pharma PLC(VRNA)Put | SPONSORED ADS | 925050106 | $8.7M | 91,800 | 2.1% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $8.3M | 100,000 | 2.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $7.2M | 1,311,840 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $6.8M | 20,970 | 1.6% |
| Proshares TR II(UGL)Call | ULTRA GOLD | 74347W601 | $5.8M | 168,000 | 1.4% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $5.6M | 10,671 | 1.3% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $4.5M | 126,285 | 1.1% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $4.0M | 40,000 | 1.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $3.8M | 104,190 | 0.9% |
| Springworks Therapeutics Inc | COM | 85205L107 | $3.0M | 63,930 | 0.7% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.0M | 316,700 | 0.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $2.7M | 14,500 | 0.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $2.6M | 96,479 | 0.6% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.1M | 12,240 | 0.5% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $2.0M | 54,515 | 0.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $2.0M | 4,400 | 0.5% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $1.5M | 41,830 | 0.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $1.4M | 5,000 | 0.3% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $1.3M | 475,361 | 0.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.3M | 22,951 | 0.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.3M | 40,000 | 0.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $1.1M | 80,000 | 0.3% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $982.6K | 34,600 | 0.2% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $808.0K | 29,200 | 0.2% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $556.1K | 41,100 | 0.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $494.7K | 27,319 | 0.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $462.0K | 20,000 | 0.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $457.3K | 30,900 | 0.1% |